|
1
|
Entschladen F, Lang K, Drell TL, Joseph J
and Zanker KS: Neurotransmitters are regulators for the migration
of tumor cells and leukocytes. Cancer Immunol Immunother.
51:467–482. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li L, Gang C and Zhang GY: Effects of
neurotransmitters on the proliferation of human hepatocytes. Chin J
Bases Clin General Surg. 9:238–241. 2002.
|
|
3
|
Wu Fy, Ou ZL and Shao ZM: Classical
neurotransmitter and cancer metastasis. Foreign Medical Sciences
(Oncology section). 32:678–680. 2005.
|
|
4
|
Watanabe M, Maemura K, Kanbara K, Tamayama
T and Hayasaki H: GABA and GABA receptors in the central nervous
system and other organs. Int Rev Cytol. 213:1–47. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Roberts E: Adventures with GABA: fifty
years on. GABA in the Nervous System. The View at Fifty Years.
Martin D and Olsen R: Lippincott Williams and Wilkins;
Philadelphia: pp. 1–24. 2000
|
|
6
|
Saito N, Taniyama K and Tanaka C: Uptake
and release of gamma-aminobutyric acid in guinea pig gallbladder.
Am J Physiol Gastrointest Liver Physiol. 249:G192–G196.
1985.PubMed/NCBI
|
|
7
|
Maemura K, Yamauchi H, Hayasaki H, et al:
Gamma-amino-butyric acid immunoreactivity in intramucosal colonic
tumors. J Gastroenterol Hepatol. 18:1089–1094. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kleinrok Z, Matuszek M, Jesipowicz J,
Matuszek B, Opolski A and Radzikowski C: GABA content and GAD
activity in colon tumors taken from patients with colon cancer or
from xenografted human colon cancer cells growing as s. c tumors in
athymic nu/nu mice. J Physiol Pharmacol. 49:303–310.
1998.PubMed/NCBI
|
|
9
|
Matuszek M, Jesipowicz M and Kleinrok Z:
GABA content and GAD activity in gastric cancer. Med Sci Monit.
7:377–381. 2001.PubMed/NCBI
|
|
10
|
Ortega A: A new role for GABA: inhibition
of tumor cell migration. Trends Pharmacol Sci. 24:151–154. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Azuma H, Inamoto T, Sakamoto T, et al:
Gamma-aminobutyric acid as a promoting factor of cancer metastasis;
induction of matrix metalloproteinase production is potentially its
underlying mechanism. Cancer Res. 63:8090–8096. 2003.
|
|
12
|
Joseph J, Niggemarm B, Zaenker KS, et al:
The neurotransmitter gamma-aminobutyric acid is an inhibitory
regulator for the migration of SW 480 colon carcinoma cells. Cancer
Res. 62:6467–6469. 2002.PubMed/NCBI
|
|
13
|
Liu CH, Huang Q and Wang C:
Gamma-aminobutyric acid-induced apoptosis and effect of telomerase
activity of cholangiocarcinoma cell line QBC939. Chin J
Hepatobiliary Surg. 15:41–44. 2009.
|
|
14
|
Wang SG, Han BL, Duan HC, et al:
Establishment of the characteristics of a cell line of extrahepatic
cholangiocarcinoma. Chin J Exp Surg. 14:67–70. 1997.
|
|
15
|
Ries C, Loher F, Zang C, Ismair MG and
Petrides PE: Matrix metalloproteinase production by bone marrow
mononuclear cells from normal individuals and patients with acute
and chronic myeloid leukemia or myelodysplastic syndromes. Clin
Cancer Res. 5:1115–1124. 1999.
|
|
16
|
Stetler-Stevenson WG and Kleiner:
Molecular biology of cancer: invasion and metastases. Cancer
Principles and Practice of Oncology. 6th edition. Devita VT,
Hellman S and Rosenberg SA: Lippincott Williams Willkins;
Philadelphia: pp. 123–136. 2001
|
|
17
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar
|
|
18
|
Chanda R and Ganguly AK: Diamine-oxidase
activity and tissue di- and poly-amine contents of human ovarian,
cervical and endometrial carcinoma. Cancer Lett. 89:23–28. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nicholson-Guthrie CS, Guthrie GD, Sutton
GP and Baenziger JC: Urine GABA levels in ovarian cancer patients:
elevated GABA in malignancy. Cancer Lett. 162:27–30. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Coussens LM, Fingleton B and Matrisian LM:
Matrix metalloproteinase inhibitors and cancer: trials and
tribulations. Science. 295:2387–2392. 2002. View Article : Google Scholar : PubMed/NCBI
|
